Nolan D - Search Results

1

Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.

Nolan D, Phillips E, Mallal S. Nolan D, et al. Clin Infect Dis. 2006 Feb 1;42(3):408-10. doi: 10.1086/499369. Epub 2005 Dec 27. Clin Infect Dis. 2006. PMID: 16392090 No abstract available.

2

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.

Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, Mallal S. Rauch A, et al. Among authors: nolan d. Clin Infect Dis. 2006 Jul 1;43(1):99-102. doi: 10.1086/504874. Epub 2006 May 26. Clin Infect Dis. 2006. PMID: 16758424

3

HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy.

Rauch A, Nolan D, Furrer H, McKinnon E, John M, Mallal S, Gaudieri S, Günthard HF, Schmid P, Battegay M, Hirschel B, Telenti A, James I; Swiss HIV Cohort Study. Rauch A, et al. Among authors: nolan d. Clin Infect Dis. 2008 Jun 15;46(12):1921-5. doi: 10.1086/588479. Clin Infect Dis. 2008. PMID: 18466093

4

Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.

Hammond E, McKinnon E, Nolan D. Hammond E, et al. Among authors: nolan d. Clin Infect Dis. 2010 Sep 1;51(5):591-9. doi: 10.1086/655765. Clin Infect Dis. 2010. PMID: 20645860

5

New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.

Pavlos R, Deshpande P, Chopra A, Leary S, Strautins K, Nolan D, Thorborn D, Shaefer M, Rauch A, Dunn D, Montaner J, Rachlis A, Almeida CA, Choo L, James I, Redwood AJ, Li Y, Gaudieri S, Mallal SA, Phillips EJ. Pavlos R, et al. Among authors: nolan d. Hum Immunol. 2020 Jun;81(6):300-304. doi: 10.1016/j.humimm.2020.02.011. Epub 2020 Mar 12. Hum Immunol. 2020. PMID: 32173028 Free PMC article.

6

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. John M, et al. Among authors: nolan d. AIDS. 2001 Apr 13;15(6):717-23. doi: 10.1097/00002030-200104130-00007. AIDS. 2001. PMID: 11371686

7

Antiretroviral therapy and the lipodystrophy syndrome.

John M, Nolan D, Mallal S. John M, et al. Among authors: nolan d. Antivir Ther. 2001 Mar;6(1):9-20. Antivir Ther. 2001. PMID: 11417766 Review.

8

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.

Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S. Nolan D, et al. AIDS. 2001 Jul 6;15(10):1275-80. doi: 10.1097/00002030-200107060-00009. AIDS. 2001. PMID: 11426072

9

Effects of sex and race on lipodystrophy pathogenesis.

Nolan D, Mallal S. Nolan D, et al. J HIV Ther. 2001 May;6(2):32-6. J HIV Ther. 2001. PMID: 11501201 Review. No abstract available.

10

Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis.

Nolan D, John M, Mallal S. Nolan D, et al. Antivir Ther. 2001 Sep;6(3):145-60. Antivir Ther. 2001. PMID: 11808750 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results